APAC Dialysis Market

APAC Dialysis Market Size (2023 to 2028)

The market size for dialysis in the APAC region is estimated to xgrow at a CAGR of 10.12% from 2023 to 2028. As a result, the market size is expected to grow to USD 43.31 billion by 2028 from USD 26.62 billion in 2023.

Y-O-Y rise in the number of people who have diabetes is primarily driving the dialysis market in this region. In 2019, nearly 78 million individuals had diabetes in India, which is expected to increase in the coming years. An increase in diabetes can also leads to nerve damage, problems in blood circulation, and kidney disease. In diabetes, Type-2 diabetes leads to chronic kidney disease, which requires dialysis.

The growing prevalence of the end-stage renal disease is further accelerating the growth of the APAC dialysis market. Diabetes and hypertension are the leading causes of end-stage renal disease. Dialysis is taken in this disease when kidney function reaches an advanced level of not working correctly. The prevalence of kidney failure deaths in India is increased in recent years compared to previous years due to unhealthy diet, smoking, consuming alcohol, etc. In India, approximately 150-200 patients have End-Stage Renal Disease (EDSR).

Furthermore, the shortage of organs is significantly growing in the Asia-Pacific region and is leading to increased dialysis procedures, promoting the market's growth rate. Demand for dialysis has increased due to the lack of organs for transplantation. There is a list of organ donors for organ transplantation in the Asia Pacific. If the person cannot have this organ transplantation due to a lack of organs, they undergo dialysis to extend their life until they get an organ for transplantation. Due to the increasing side effects of transplantation, dialysis is the most preferred for kidney and liver failure patients to remove waste from the body. Side effects of transplantation are high blood pressure, high cholesterol, anemia, arthritis, and weakened bones.

In addition, increasing demand for home dialysis and advancements in dialysis products favor growing the market. Due to the number of kidney failure patients, dialysis is increased. Moreover, during the pandemic, dialysis at hospitals has a chance to spread viruses in patients. Therefore, at this time, home dialysis has been adopted by most dialysis patients at their convenience at a convenient time. Moreover, more patients are preferred eco-friendly dialysis in the use of dialysis. As a result, Key players in this region are focusing on manufacturing advanced and cost-effective products.

However, the high costs associated with dialysis procedures are significantly hampering the growth of the dialysis market in the APAC region. In addition, strict regulatory policies, lack of approvals of dialysis products, lack of awareness about dialysis among rural people, and lack of trained professionals further hamper the dialysis market growth in the Asia Pacific.

This report on the APAC Dialysis market has been segmented and sub-segmented into the following categories.

By Type:

• Products
• Services

By Dialysis Type:

• Hemodialysis
• Peritoneal Dialysis

By End-User:

• Dialysis Centers & Hospitals
• Home Care 

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, the Asia Pacific market is anticipated to hold a prominent share of the global market during the forecast period and is also the fastest-growing regional market. Peritoneal dialysis is the most done dialysis in China. It has been used in China for over 30 years to treat end-stage kidney disease patients. The Chinese government has launched the most advanced treatments and products for dialysis patients to increase their life span. In addition, training programs have been conducted in hospitals to know the use of refined products in dialysis.

The Indian dialysis market is anticipated to showcase rapid growth in this region. This is because the prevalence of kidney failure deaths in India is more significant than in previous years. Therefore, hemodialysis (HD) is the most dialysis in India public, and private hospitals in large cities are adopting this dialysis for patients suffering from kidney failure.

On the other hand, the Japanese dialysis market is expected to grow at a significant CAGR in the coming years. One of the world’s highest numbers of dialysis users is in Japan. In Japan, patients receiving hemodialysis who are not undergoing transplantation. In Japan, patients having dialysis have a health insurance system for good prognosis in treatment. However, insurance is increasing due to using more expensive convective therapies.

KEY MARKET PLAYERS:

Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Diaverum Healthcare Partners, Medtronic, Asahi Kasei Corporation, and Nipro Corporation are some of the companies playing a vital role in the APAC dialysis market profiled in this report.